Projecting future drug, expenditures - 2006

James M. Hoffman, Nilay D. Shah, Lee C. Vermeulen, Glen T. Schumock, Penny Grim, Robert J. Hunkler, Karrie M. Hontz

Research output: Contribution to journalReview article

33 Scopus citations

Abstract

Purpose. Drug expenditure trends in 2004 and 2005, projected drug expenditures for 2006, and factors likely to influence drug costs are discussed. Sammary. Various factors are likely to affect drug costs, including drug prices, drugs in development, and generic drugs, in 2004 there was a continued moderation of the increase in drug expenditures. Drug expenditures increased by 8.7% from 2003 to 2004. Through the first nine months of 2005, expenditures increased by only 8.1% compared with 2004. This moderation can be attributed to several factors, including the continued trend toward higher prescription drug cost sharing for insured consumers, growing availability of generic drugs, and lack of "blockbuster" new drugs in recent years. Drug expenditures in 2006 will likely be influenced by similar factors, with few costly new products reaching the market, increased concern over product safety slowing the diffusion of those new agents that do reach the market, and several important patent expirations, leading to slower growth in expenditures. Conduced. Forecasting and managing rising drug expenditures remains a challenge. Pharmacy managers must remain vigilant in monitoring drug costs in their health system and take a proactive role in pursuing efficient drug utilization. The dynamic health policy environment further complicates drug budgeting and must be considered, especially in integrated health systems responsible for managing inpatient, outpatient, and clinic drug costs. The comparison of health-system-specific data and trends with the national information presented in this article may provide a useful context when presenting institutional drug costs to senior management.

Original languageEnglish (US)
Pages (from-to)123-138
Number of pages16
JournalAmerican Journal of Health-System Pharmacy
Volume63
Issue number2
DOIs
StatePublished - Jan 15 2006

Keywords

  • Administration
  • Budgets
  • Control
  • Costs
  • Drug use
  • Drugs
  • Economics
  • Patents
  • Pharmacy, institutional, hospital
  • Prescriptions
  • Pricing
  • Product development
  • Rational therapy
  • Toxicity

ASJC Scopus subject areas

  • Pharmacology
  • Health Policy

Fingerprint Dive into the research topics of 'Projecting future drug, expenditures - 2006'. Together they form a unique fingerprint.

  • Cite this

    Hoffman, J. M., Shah, N. D., Vermeulen, L. C., Schumock, G. T., Grim, P., Hunkler, R. J., & Hontz, K. M. (2006). Projecting future drug, expenditures - 2006. American Journal of Health-System Pharmacy, 63(2), 123-138. https://doi.org/10.2146/ajhp050446